* Allscripts Healthcare Solutions Inc MDRX.OQ MDRX.O is
expected to show a fall in quarterly revenue when it reports
results on April 29.
* The Chicago, Illinois-based company is expected to report a
11.5% decrease in revenue to $368.657 million from $416.7
million a year ago, according to the mean estimate from 12
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Allscripts Healthcare
Solutions Inc is for earnings of 15 cents per share. For the
same quarter last year, the company reported earnings of 9 cents
per share.
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 5 "strong buy" or "buy," 10
"hold" and 2 "sell" or "strong sell."
* The mean earnings estimate of analysts had fallen by
about 0.2% in the last three months.
* Wall Street's median 12-month price target for Allscripts
Healthcare Solutions Inc is $15, about 7.6% below its last
closing price of $16.14.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Dec. 31 2020 0.22 0.21 0.29 Beat 36.6
Sep. 30 2020 0.19 0.19 0.20 Beat 5.6
Jun. 30 2020 0.12 0.12 0.18 Beat 49.3
Mar. 31 2020 0.14 0.15 0.09 Missed -39.4
Dec. 0.18 0.18 0.17 Missed -7
31 2019
Sep. 30 2019 0.17 0.17 0.17 Met 1.8
Jun. 30 2019 0.16 0.16 0.17 Beat 5.1
Mar. 31 2019 0.14 0.14 0.16 Beat 12.6
This summary was machine generated April 27 at 21:32 GMT. All
figures in US dollars unless otherwise stated